DOJ Charges 455 in $6.5B Health Fraud Sweep; FTC Targets AI Accuracy
Digital health, telehealth, and AI-in-medicine leaders face fresh enforcement and regulatory signals from DOJ's June takedown, the FTC's AI accuracy proposal, and CMS's new AI office.
The DOJ's 2026 National Health Care Fraud Takedown charged 455 defendants tied to over $6.5 billion in alleged false claims, with telemedicine, DME, and genetic-testing schemes prominently featured. A nurse practitioner was sentenced to 10 years for a $136 million Medicare fraud, and CMS suspended or revoked billing privileges for more than 2,400 providers. Separately, the FTC released a proposed policy statement warning that AI developers may train models to suppress accuracy, with comments due July 31, 2026. CMS launched a new Office of Health Technology and Products to coordinate AI strategy, while the House Appropriations Committee advanced an FY27 spending bill prohibiting CMS funding for the WISeR AI prior-authorization model. The FDA issued a warning letter on unauthorized software changes to a patient monitoring device and announced a public meeting on medical device user-fee reauthorization focused on digital health oversight. In-house counsel should review telehealth compliance programs, AI governance disclosures, and prior-authorization exposure.